Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

312.00p
   
  • Change Today:
    -16.50p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.00m
  • Volume: 92,786
  • Market Cap: £330.72m
  • RiskGrade: 125

Latest ShareCast News

Oxford Biomedica reports first-half revenue growth

By Josh White

Date: Monday 23 Sep 2024

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.

OXB Regulatory News

Grant of options 16-May-2025 17:52 RNS
Total Voting Rights 01-May-2025 07:00 RNS
Person Closely Associated Dealing 30-Apr-2025 16:49 RNS
Holding(s) in Company 29-Apr-2025 18:14 RNS
2025 Annual General Meeting notification 28-Apr-2025 13:00 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 312.00p
Change Today -16.50p
% Change -5.02 %
52 Week High 445.00
52 Week Low 232.50
Volume 92,786
Shares Issued 106.00m
Market Cap £330.72m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.02% below the market average31.02% below the market average31.02% below the market average31.02% below the market average31.02% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Price Trend
34.29% below the market average34.29% below the market average34.29% below the market average34.29% below the market average34.29% below the market average
10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average
Income Not Available
Growth
2.11% above the market average2.11% above the market average2.11% above the market average2.11% above the market average2.11% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
16:35 19,023 @ 312.00p
16:35 133 @ 312.00p
16:35 68 @ 312.00p
16:35 31 @ 312.00p
16:35 420 @ 312.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page